Clinical Trial

Effectiveness of E-prf Alone and in Combination With Bioactive Glass Nanoparticles in Grade II Furcation Defects

Completed
View on ClinicalTrials.gov →
Summary
The aim of the study is to evaluate and compare the effectiveness of extended platelet-rich fibrin (ePRF) alone and in combination with bioactive glass nanoparticles in the treatment of grade II furcation defects clinically and radiographically.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-26.
Status change: Active, Not Recruiting → Completed 2026-01-12
Trial Details
NCT Number NCT07042204
Lead Sponsor Merna Nasser Mohamed Mostafa Ibrahim Elnahas
Conditions Furcation Defects
Enrollment 30 participants
Start Date 2024-01-03
Primary Completion 2025-06-03 (estimated)
Study Completion 2025-08-03 (estimated)
Updated on ClinicalTrials.gov 2026-01-13